Consorci Sanitari Integral
16
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
An Educational Intervention on Medication Adverse Effects in Patients With Resistant Hypertension (HTAR-CSI)
Role: lead
Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy
Role: lead
Breathing Pattern Description in Pneumonia Patients
Role: lead
Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients
Role: lead
Prevention of Parastomal Hernias With a Preformed Three-dimensional, Funnel-shaped Mesh
Role: lead
Perioperative Management of Preoperative Anemia in Colorectal Cancer
Role: lead
Two Hypoabsorption Techniques for the Treatment of Type III Obesity (OASIS)
Role: lead
Nutritional Support and Telemedicine
Role: lead
IMAGINE Study Protocol
Role: collaborator
Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes
Role: lead
Arthroscopic Diagnosis and Treatment of Dorsal Wrist Syndrome in Patients With Synovial Hypertrophy
Role: lead
Election of the Optimal Moment of Colecistectomy After Mild Biliary Pancreatitis
Role: lead
Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis
Role: lead
Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic Landmarks
Role: lead
Radical Laparoscopic Prostatectomy. Enhanced Recovery After Surgery (ERAS) Program
Role: lead
A Trial of Single Incision Versus Four Ports Laparoscopic Cholecystectomy
Role: lead
All 16 trials loaded